original ) (raw )Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation
Laura Cudillo , P. Fabritiis
The Hematology Journal, 2004
View PDFchevron_right
No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease
Bernd Gruhn
Bone Marrow Transplantation, 2021
View PDFchevron_right
Post-relapse survival in patients with Ewing sarcoma
stefania di girolamo
Pediatric Blood & Cancer, 2015
View PDFchevron_right
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
R. Capanna
Annals of Oncology, 2011
View PDFchevron_right
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
James Wade
Blood, 2007
View PDFchevron_right
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors
Jean-yves Cahn
Blood, 2004
View PDFchevron_right
Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies
Ryuji Tanosaki
British Journal of Haematology, 2003
View PDFchevron_right
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant
Keiren Maris
Bone Marrow Transplantation, 2008
View PDFchevron_right
Therapy and survival after recurrence of Ewing’s tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997
Cristiana Forni
Annals of Oncology, 2003
View PDFchevron_right
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis
ANDY CHEN
Blood advances, 2018
View PDFchevron_right
Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial
James Wade
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right
Comparison of Outcomes after Two Standards-of-Care Reduced-Intensity Conditioning Regimens and Two Different Graft Sources for Allogeneic Stem Cell Transplantation in Adults with Hematologic Diseases: A Single-Center Analysis
Nicolas Blin
Biology of Blood and Marrow Transplantation, 2013
View PDFchevron_right
Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse of Malignant Disease: retrospective Analysis of Outcome and Predictive Factors
A. Van Biezen
View PDFchevron_right
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome
Wolfgang Bethge
Experimental Hematology, 2003
View PDFchevron_right
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
Veronika Bachanova
Leukemia, 2014
View PDFchevron_right
Graft-versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning
Michael Maris
Blood, 2004
View PDFchevron_right
Long-term follow-up of allogeneic haematopoietic stem cell transplantation for solid cancer
Peter Wersäll
Biology of Blood and Marrow Transplantation, 2015
View PDFchevron_right
Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation
Nicolas Blin
Biology of Blood and Marrow Transplantation, 2017
View PDFchevron_right
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Daniel Olive
Experimental Hematology, 2003
View PDFchevron_right
A Novel Reduced Intensity Conditioning Regimen for Patients with High Risk Hematologic Malignancies Undergoing Conventional Allogeneic Stem Cell Transplantation
Hugo Castro-Malaspina
Biology of Blood and Marrow Transplantation, 2014
View PDFchevron_right
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
Veronika Bachanova
Biology of Blood and Marrow Transplantation, 2019
View PDFchevron_right
Efficacy of high dose chemotherapy in adult patients with relapsed or refractory ewing sarcoma
Alper Topal
Medicine Science | International Medical Journal
View PDFchevron_right
Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC
Eric Deconinck
Biology of Blood and Marrow Transplantation, 2012
View PDFchevron_right
Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning
Chantal Lechanteur
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right